Related Experiment Video

Updated: Jul 9, 2026

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at

M S Song1, S J Song, S J Kim

  • 1Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Korea.

Oncogene
|December 12, 2007
PubMed

Insights

The Skp2 protein targets the tumor suppressor RASSF1A for degradation, impacting cell cycle progression. This discovery reveals a key mechanism in cancer cell proliferation and survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The tumor suppressor RASSF1A plays a critical role in regulating cell cycle, apoptosis, and microtubule stability.
  • Inactivation of RASSF1A is frequently observed in various human cancers, highlighting its significance in tumorigenesis.
  • The precise mechanisms governing RASSF1A function and its regulation are not fully understood.

Purpose of the Study:

  • To elucidate the regulatory mechanisms controlling RASSF1A stability and function.
  • To investigate the role of Skp2 in the degradation of RASSF1A.
  • To determine the impact of Skp2-mediated RASSF1A degradation on cell cycle progression and proliferation.

Main Methods:

  • Co-immunoprecipitation assays to confirm the interaction between Skp2 and RASSF1A.
  • Western blotting to assess RASSF1A ubiquitination and degradation.
  • Cell cycle analysis using flow cytometry.
  • Site-directed mutagenesis to investigate the role of RASSF1A phosphorylation at Serine-203.
  • Gene silencing techniques (siRNA) to deplete Skp2 or RASSF1A levels.

Main Results:

  • Skp2 directly interacts with, ubiquitinates, and promotes the degradation of RASSF1A.
  • RASSF1A degradation by Skp2 occurs at the G1-S phase transition.
  • Phosphorylation of RASSF1A at Serine-203 by cyclin D-CDK4 is essential for Skp2-mediated degradation.
  • Mutation of Serine-203 to alanine in RASSF1A leads to delayed G1-S phase progression.
  • Overexpression of Skp2 abrogates RASSF1A's inhibitory effect on cell proliferation.
  • Depletion of RASSF1A rescues the G1-S progression delay caused by Skp2 removal.

Conclusions:

  • Skp2-mediated degradation of RASSF1A is a critical regulatory mechanism controlling cell proliferation.
  • The phosphorylation of RASSF1A at Serine-203 by cyclin D-CDK4 is a prerequisite for its Skp2-dependent degradation.
  • Targeting the Skp2-RASSF1A pathway may offer therapeutic strategies for cancers with RASSF1A inactivation.

More Related Videos

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...